NeoGenomics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NeoGenomics and other ETFs, options, and stocks.

About NEO

NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. The company was founded by Michael T. 

CEO
Anthony P. Zook
CEOAnthony P. Zook
Employees
2,500
Employees2,500
Headquarters
Fort Myers, Florida
HeadquartersFort Myers, Florida
Founded
1998
Founded1998
Employees
2,500
Employees2,500

NEO Key Statistics

Market cap
1.45B
Market cap1.45B
Price-Earnings ratio
-14.40
Price-Earnings ratio-14.40
Dividend yield
Dividend yield
Average volume
3.67M
Average volume3.67M
High today
$11.21
High today$11.21
Low today
$10.44
Low today$10.44
Open price
$10.56
Open price$10.56
Volume
6.59M
Volume6.59M
52 Week high
$13.74
52 Week high$13.74
52 Week low
$4.72
52 Week low$4.72

Stock Snapshot

The current NeoGenomics(NEO) stock price is $11.13, with a market capitalization of 1.45B. The stock trades at a price-to-earnings (P/E) ratio of -14.40.

During the trading session on 2026-06-18, NeoGenomics(NEO) shares reached a daily high of $11.21 and a low of $10.44. At a current price of $11.13, the stock is +6.6% higher than the low and still -0.7% under the high.

Trading volume for NeoGenomics(NEO) stock has reached 6.59M, versus its average volume of 3.67M.

Over the past 52 weeks, NeoGenomics(NEO) stock has traded between a high of $13.74 and a low of $4.72.

Over the past 52 weeks, NeoGenomics(NEO) stock has traded between a high of $13.74 and a low of $4.72.

NEO News

TipRanks 1d
NeoGenomics Insider Move: Director’s Share Sale Sparks Fresh Market Buzz

New insider activity at NeoGenomics ( (NEO) ) has taken place on June 17, 2026. Claim 55% Off TipRanks Unlock powerful investing tools and data-driven insights...

TipRanks 2d
NeoGenomics announces pricing of $275M convertible senior notes offering

NeoGenomics (NEO) announced the pricing of its previously announced private offering of $275M aggregate principal amount of 0.75% convertible senior notes due 2...

Analyst ratings

67%

of 12 ratings
Buy
66.7%
Hold
33.3%
Sell
0%

People also own

Based on the portfolios of people who own NEO. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.